Skip to content

Decipher Prostate RP
Test Report Overview

We want you to feel confident in every treatment decision you make using Decipher Prostate for your patients with prostate cancer, beginning with a clear understanding of how to interpret the key components of the RP test report.

View Interactive Test Report
Home > Decipher Prostate > Physicians > RP Test Report Overview

Page 1 contains the Decipher Score, risk estimates, and an interpretation of the score.

1

1. Dynamic Report

The report is tailored to the clinical presentation of this patient

 2

2. Decipher Score

  • Reflects genomic risk of metastasis
  • Determined by tumor biology alone, independent of clinical & pathological factors (e.g., Gleason, PSA)
  • 22 genes, 7 biological pathways
  • Continuous genomic risk score classified as low, intermediate or high
 3

3. Interpretation

Summary based on this patient’s genomic risk & relevant clinical findings

 4

4. Risk Estimates

  • Calibrated to outcomes of patients after surgery with undetectable, persistently-elevated, or rising PSA
    • Metastasis at 5 & 10 years
    • Prostate Cancer Mortality at 15 years

Page 2 contains case analysis, interpretation, and clinical findings.

5

5. Interpretation

  • Explains risk comparison graphic
  • Provides this patient’s percentile rank in the tested population
 6

6. Risk Comparisons 

  • This patient’s 10-year risk of metastasis with respect to 3,013 other patients with Gleason 4+3=7 disease & rising PSA
  • The distribution of Decipher risk within the 3,013 patients is:
    • 19% Decipher Low
    • 16% Decipher Int.
    • 65% Decipher High
 7

7. Treatment Graphics

  • Treatment Timing (Left)
    • Risk of metastasis after post-RP radiation stratified by Decipher risk & PSA level at time of treatment
  • Treatment Intensity (Right)
    • Risk of receiving salvage ADT after radiation alone stratified by Decipher risk & PSA level at time of treatment
 8

8. Clinical Findings

Clinical study results relevant to this patient

Page 3 contains a test description, intended use info, confidence intervals, and references.

9

9. Test Description

  • Description of:
    • Decipher testing platform technology
    • Risk estimates
    • Cut-points separating Decipher low, intermediate & high
 10

10. Intended Use

Decipher Prostate RP is intended for use in post-RP specimens from localized prostate cancer patients with undetectable, persistent, or rising PSA

 11

11. Confidence Intervals

The 95% confidence intervals for each risk estimate (on page 1)

 12

12. References

For each of the clinical studies cited in the report